Table 9. Objective Response to Neoadjuvant Chemotherapy.
Authors | n | CR+PR | SD+PD |
Shchepotin et al [41] | 47 | 41 (87.1%) | 6 (12.9%) |
Hartgrink et al [45] | 25 | 8 (32%) | 17 (68%); 10 SD+7 PD |
Nio et al [46] | 87 | 29 (33.3%); 2 CR+27 PR | 58 (66.7%); 58 CR+0 PD |
Imano et al [48] | 16 | 1 (6.25%); 0 CR+1 PR | 15 (93.75%); 15 SD+0 PD |
Schuhmacher et al [49] | 69 | 26 (37.68%); 5 CR+21 PR | 43 (62.32%); 39 SD+4 PD |
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.